Chinese drug regulators approve the world's first inhalable Covid-19 vaccine, made by Tianjin-based manufacturer CanSino Biologics
Chinese drug regulators have approved the world's first inhalable Covid-19 vaccine, made by Tianjin-based manufacturer CanSino Biologics, boosting the company's share price by seven percent.
"The approval will have a positive impact on the company's performance if the vaccine is subsequently purchased and used by relevant government agencies," the company said in a statement to the Hong Kong Stock Exchange. The company did not offer details on when the adenovirus-vectored vaccine, which a Lancet report in July 2021 said induced strong antibody responses, will be made available for public use.Scientists in several countries including Cuba, Canada and the United States are also trialing inhalable Covid-19 vaccines.But the country's drug administrator is yet to greenlight any foreign vaccines, including mRNA shots produced by Pfizer/BioNTech or Moderna.
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Transverse Leukonychia and Beau Lines Following COVID-19 VaccinationGiven accelerated global vaccination efforts to control the COVID-19 pandemic, cases of nail changes associated with COVID-19 vaccines are expected.
Weiterlesen »
The World's First Needle-Free COVID Vaccine Just Got Approved in ChinaJust one breath of a vaccine mist can provide strong immune protection against COVID-19, vaccine maker CanSino said in a news release Sunday (Sept.
Weiterlesen »
What you need to know about the new omicron booster shotsCOVID-19 vaccine approval and dosing guidance may soon be similar to how we handle flu shots. CovidIsNotOver COVID19 Booster COVIDBooster publichealth
Weiterlesen »
Paxlovid Rebound in COVID-19: Where We Stand on Drug Regimens.DrRobertGlatter and PaulPauwaert discuss Paxlovid rebound and recommendations for patients with COVID-19. MedTwitter
Weiterlesen »